Francesca Ruscitti Corporate Preclinical R&D Chiesi Farmaceutici S.p.A. Biography Publications Institution JoVE Articles Francesca Ruscitti has not added a biography. If you are Francesca Ruscitti and would like to personalize this page please email our Author Liaison for assistance. Publications Longitudinal Assessment of Bleomycin-induced Lung Fibrosis by Micro-CT Correlates with Histological Evaluation in Mice Multidisciplinary Respiratory Medicine. 2017 | Pubmed ID: 28400960 Heterologous Matrix Metalloproteinase Gene Promoter Activity Allows In Vivo Real-time Imaging of Bleomycin-Induced Lung Fibrosis in Transiently Transgenized Mice Frontiers in Immunology. 2017 | Pubmed ID: 28298912 In Vivo Monitoring of Lung Inflammation in CFTR-deficient Mice Journal of Translational Medicine. Jul, 2016 | Pubmed ID: 27468800 Assessment of Asthmatic Inflammation Using Hybrid Fluorescence Molecular Tomography-x-ray Computed Tomography Journal of Biomedical Optics. Jan, 2016 | Pubmed ID: 26803669 Monitoring Inflammation and Airway Remodeling by Fluorescence Molecular Tomography in a Chronic Asthma Model Journal of Translational Medicine. Oct, 2015 | Pubmed ID: 26496719 In Vivo Imaging of the Lung Inflammatory Response to Pseudomonas Aeruginosa and Its Modulation by Azithromycin Journal of Translational Medicine. Aug, 2015 | Pubmed ID: 26239109 Azithromycin Inhibits Nuclear Factor-κB Activation During Lung Inflammation: an in Vivo Imaging Study Pharmacology Research & Perspectives. Oct, 2014 | Pubmed ID: 25505605 Enlightened Mannhemia Haemolytica Lung Inflammation in Bovinized Mice Veterinary Research. Jan, 2014 | Pubmed ID: 24460618 Hydrogen Sulfide Inhibits IL-8 Expression in Human Keratinocytes Via MAP Kinase Signaling Laboratory Investigation; a Journal of Technical Methods and Pathology. Aug, 2011 | Pubmed ID: 21555999 Мультимодального Imaging подход на основе микро CT и флуоресценции молекулярные томографии для продольной оценки фиброза блеомицин индуцированного легких у мышей Francesca Ruscitti1, Francesca Ravanetti2, Gaetano Donofrio2, Yanto Ridwan3, Paula van Heijningen3, Jeroen Essers4, Gino Villetti1, Antonio Cacchioli2, Wim Vos5, Franco Fabio Stellari1 1Corporate Preclinical R&D, Chiesi Farmaceutici S.p.A., 2Department of Veterinary Science, University of Parma, 3Department of Molecular Genetics, Erasmus MC, 4Department of Molecular Genetics, Vascular Surgery, Radiation Oncology, Erasmus MC, 5Fluidda NV JoVE 56443 Immunology and Infection Модель переходной трансгенерации IL-8 для Gabriella Bergamini*1, Fabio Stellari*2, Angela Sandri*3, Maria M. Lleo3, Gaetano Donofrio4, Francesca Ruscitti5,2, Federico Boschi6, Andrea Sbarbati7, Gino Villetti2, Paola Melotti8, Claudio Sorio1 1Department of Medicine, General Pathology Division, Cystic Fibrosis Translational Research Laboratory "D. Lissandrini", University of Verona, 2Corporate Preclinical R&D, Chiesi Farmaceutici S.p.A., 3Department of Diagnostic and Public Health, Microbiology Division, University of Verona, 4Dipartimento di Scienze Medico-Veterinarie, University of Parma, 5Department of Biomedical Biotechnological and Translational Sciences, University of Parma, 6Department of Computer Science, University of Verona, 7Department of Neurological, Biomedical and Movement Sciences, University of Verona, 8Cystic Fibrosis Regional Center (CFC), AOUI Verona JoVE 55499 Immunology and Infection
Мультимодального Imaging подход на основе микро CT и флуоресценции молекулярные томографии для продольной оценки фиброза блеомицин индуцированного легких у мышей Francesca Ruscitti1, Francesca Ravanetti2, Gaetano Donofrio2, Yanto Ridwan3, Paula van Heijningen3, Jeroen Essers4, Gino Villetti1, Antonio Cacchioli2, Wim Vos5, Franco Fabio Stellari1 1Corporate Preclinical R&D, Chiesi Farmaceutici S.p.A., 2Department of Veterinary Science, University of Parma, 3Department of Molecular Genetics, Erasmus MC, 4Department of Molecular Genetics, Vascular Surgery, Radiation Oncology, Erasmus MC, 5Fluidda NV JoVE 56443 Immunology and Infection
Модель переходной трансгенерации IL-8 для Gabriella Bergamini*1, Fabio Stellari*2, Angela Sandri*3, Maria M. Lleo3, Gaetano Donofrio4, Francesca Ruscitti5,2, Federico Boschi6, Andrea Sbarbati7, Gino Villetti2, Paola Melotti8, Claudio Sorio1 1Department of Medicine, General Pathology Division, Cystic Fibrosis Translational Research Laboratory "D. Lissandrini", University of Verona, 2Corporate Preclinical R&D, Chiesi Farmaceutici S.p.A., 3Department of Diagnostic and Public Health, Microbiology Division, University of Verona, 4Dipartimento di Scienze Medico-Veterinarie, University of Parma, 5Department of Biomedical Biotechnological and Translational Sciences, University of Parma, 6Department of Computer Science, University of Verona, 7Department of Neurological, Biomedical and Movement Sciences, University of Verona, 8Cystic Fibrosis Regional Center (CFC), AOUI Verona JoVE 55499 Immunology and Infection
